Although not fully elucidated, the mechanism by which SCD inhibition mitigates αSyn toxicity appears to be through influencing the dynamics of αSyn interaction with vesicle membranes and structural state vs. lipidic aggregation and degeneration of dopaminergic and other brain neurons in PD-like mice [29]. The gene discussed is SCD; the disease is Parkinson disease.